A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study (vol 127, pg 538, 2012)

Coleman Robert L<sup>*</sup>; Sill Michael W; Lankes Heather A; Fader Amanda Nickles; Finkler Neil J; Hoffman James S; Rose Peter G; Sutton Gregory P; Drescher Charles W; McMeekin D Scott; Hu Wei; Deavers Michael; Godwin Andrew K; Alpaugh R Katherine; Sood Anil K

doi:10.1016/j.ygyno.2013.04.007

免费注册

赞收藏引用

科研之友

微信

新浪微博

Facebook

分享链接

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study (vol 127, pg 538, 2012)

作者：Coleman Robert L^*; Sill Michael W; Lankes Heather A; Fader Amanda Nickles; Finkler Neil J; Hoffman James S; Rose Peter G; Sutton Gregory P; Drescher Charles W; McMeekin D Scott; Hu Wei; Deavers Michael; Godwin Andrew K; Alpaugh R Katherine; Sood Anil K

来源：Gynecologic Oncology, 2013, 130(1): 252-253.

DOI：10.1016/j.ygyno.2013.04.007